Reticulocyte Count
Reticulocytes are immature red blood cells freshly released from bone marrow. This count reflects how actively your bone marrow is producing red blood cells and helps classify the cause of anaemia.
- DHA-licensed lab
- Includes Doctor Consultation
- Physician-reviewed
- Same Day Collection
24 hours
Turnaround
Blood
Sample
What the Reticulocyte Count test tells you
Reticulocytes are red blood cells that have just left the bone marrow and have not quite finished maturing. They still carry remnants of the machinery used to build haemoglobin, which is what allows the laboratory to distinguish them from fully mature red cells. They complete their maturation over a short period in the circulation, so at any moment the number present is a snapshot of how many new red cells the marrow released very recently.
That makes this test the most direct way of answering a single, decisive question: is the bone marrow responding? The question matters because anaemia arises in two fundamentally different ways. Red cells may be produced too slowly, as happens with iron, vitamin B12 or folate deficiency, in marrow failure, in chronic kidney disease and during long-standing inflammation. Or red cells may be produced normally but lost or destroyed faster than they can be replaced, as happens with bleeding and with haemolysis. Haemoglobin alone cannot separate those two situations, because both simply look like anaemia. The reticulocyte count separates them straight away: a marrow working hard against ongoing loss produces many young cells, while a marrow that cannot produce releases few, however anaemic the person is.
The same logic makes it the earliest confirmation that treatment is working. When iron, vitamin B12 or folate is replaced in someone who was deficient, young red cells appear in the circulation well before haemoglobin has risen enough to be convincing, so an early rise in reticulocytes tells your doctor the diagnosis was right and the treatment is being absorbed. Because raw numbers can mislead when anaemia is severe, laboratories usually correct the figure or express it as an index, and a recent transfusion temporarily suppresses the marrow's own output and can flatten the result.
Critical for classifying anaemia: distinguishing between conditions where the bone marrow is responding appropriately versus those where marrow production is impaired.
- Classifying the anaemia
It separates anaemia caused by underproduction from anaemia caused by bleeding or destruction, which haemoglobin alone cannot do.
- Checking marrow response
It shows directly whether the bone marrow is producing red cells at the rate the situation demands.
- Confirming treatment works
A rise in young red cells is the earliest laboratory sign that iron, vitamin B12 or folate replacement is taking effect.
- Detecting ongoing red cell loss
A sustained high count points toward continuing bleeding or destruction of red cells somewhere in the body.
Reasons your doctor may request the Reticulocyte Count test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
Explaining anaemia
- Anaemia has been found and the underlying reason is not yet clear.
- Haemolysis is suspected because of jaundice, dark urine or an enlarged spleen.
- Bone marrow failure or aplastic anaemia is being considered.
Response to treatment
- Iron, vitamin B12 or folate treatment has started and its early effect needs confirming.
- You are receiving erythropoietin or recovering after a bone marrow transplant.
Reticulocytes are newly released red cells, so the figure shows how hard your marrow is working right now. A Normal result, 0.5 to 2.5 %, indicates steady production. A Low result, 0 to 0.4 %, means production is not keeping up: iron, vitamin B12 or folate deficiency before treatment, marrow suppression from chemotherapy, chronic kidney disease or long-standing inflammation. A High result, 2.6 to 6 %, means the marrow is responding: to bleeding, to red cells being destroyed, or to the first weeks of replacement treatment. Context changes the reading. When anaemia is severe the raw percentage overstates the response, so laboratories correct it or report it as an index; a recent transfusion damps your own output; and sampled too soon after treatment starts, the expected rise has not appeared yet. Your doctor reads it with your blood count, your iron and vitamin results and your symptoms.
Medically reviewed by Dr Nirupama Sabhapathy
Ranges are a guide: your physician interprets your result alongside your symptoms and history.
What a higher result can point to
- Bleeding, as the marrow works to replace red cells that have been lost.
- Haemolysis, where red cells are destroyed faster than usual and production increases to compensate.
- The first response to iron, vitamin B12 or folate replacement in someone who was deficient.
- Erythropoietin treatment, or recovery of the marrow after a period of suppression.
- Chronic low oxygen from lung disease or prolonged life at altitude.
What a lower result can point to
- Iron, vitamin B12 or folate deficiency before any treatment has begun.
- Bone marrow failure, aplastic anaemia or infiltration of the marrow by disease.
- Chemotherapy, radiotherapy and other marrow-suppressing medicines.
- Chronic kidney disease, through loss of the hormone signal that drives red cell production.
- Long-standing inflammation, which dampens the marrow's response to anaemia.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests: your doctor decides what it means for you.
What this test cannot tell you
- The raw figure can mislead when anaemia is severe, so laboratories usually correct it or report it as an index before it is interpreted.
- A recent transfusion suppresses the marrow's own output temporarily and can mask a genuine response.
- It shows whether the marrow is responding but never says why it is or is not, so it always needs interpreting alongside other tests.
- Timing matters: sampled too soon after treatment begins, the expected response has simply not appeared yet.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1Reticulocytes are newly released red cells that still carry traces of their production machinery.
- 2The count is a direct read-out of how hard the bone marrow is currently working.
- 3A high count with anaemia points toward blood loss or destruction of red cells.
- 4A low count with anaemia points toward a problem with production.
- 5It is the earliest laboratory sign that treatment for a nutritional anaemia is working.
- HaematologyComplete Blood Count (CBC)
The CBC is the most commonly ordered blood test. It measures red blood cells, white blood cells, haemoglobin, haematocrit, and platelets to assess…
35View - HaematologyHemoglobin (Hb)
Haemoglobin is the oxygen-carrying protein in red blood cells. This test measures haemoglobin levels to detect anaemia, polycythemia, or monitor…
25View - BiochemistryFerritin
Ferritin reflects your body's iron stores. Low levels indicate iron deficiency (even before anaemia develops), while very high levels may suggest…
55View - Vitamins & MineralsVitamin B12 (Cyanocobalamin)
Vitamin B12 is essential for nerve function, DNA synthesis, and red blood cell production. Deficiency can cause anaemia, neurological damage, and…
50View
Frequently Asked Questions
Everything you need to know about the Reticulocyte Count test. Can't find what you're looking for?
Talk to our team→Our laboratory reports 0.5 to 2.5 % as normal, indicating steady red cell production. A result of 0 to 0.4 % is reported as low, meaning production is not keeping up, and 2.6 to 6 % as high, meaning the marrow is responding to loss, destruction or treatment. Your doctor reads it with your blood count and iron and vitamin results.
A low count means the bone marrow is not producing enough new red cells. Common reasons are iron, vitamin B12 or folate deficiency before treatment, chemotherapy or other marrow-suppressing medicines, chronic kidney disease and long-standing inflammation. Less often it reflects marrow failure or disease infiltrating the marrow. With anaemia, it points your doctor towards a production problem.
When anaemia is severe, the raw percentage overstates how hard the marrow is working, because the young cells are being counted against fewer red cells overall. Laboratories therefore correct the figure for the degree of anaemia or report it as an index before it is interpreted. Your doctor uses the corrected value to judge whether the marrow response is adequate.
Yes. A recent transfusion temporarily suppresses your own marrow output and can flatten the count, masking a genuine response. Chemotherapy lowers it, while erythropoietin treatment raises it. Mention any transfusion in the recent past and these treatments when you give the sample, so the result is read in the right context.
It means the marrow is producing extra red cells and keeping pace. This can follow recent bleeding that has been replaced, red cells being destroyed faster than usual with production compensating, recovery after a period of marrow suppression, erythropoietin treatment, or chronic low oxygen from lung disease or a recent stay at high altitude. Your doctor looks at which fits your history.
It is a red blood cell that has just been released from the bone marrow and has not finished maturing. It still contains remnants of the machinery used to make haemoglobin, which the laboratory can stain and identify, and it matures fully after a short period in the circulation.
Haemoglobin tells your doctor that anaemia is present but not whether the marrow is trying to correct it. Adding the reticulocyte count answers that question, and the combination separates anaemia of underproduction from anaemia of loss or destruction.
It suggests the marrow is working hard and the problem lies elsewhere, most often ongoing bleeding or destruction of red cells in the circulation. Your doctor will then look for the source of the loss or evidence of haemolysis rather than at production.
Faster than haemoglobin does. Young red cells begin appearing in the circulation within a matter of days of effective replacement, typically peaking during the first week or two, which is why this test is used as an early confirmation that the treatment is right.
No. No fasting is needed and you can take your usual medicines. If the test is checking that iron, vitamin B12 or folate treatment is working, keep to the date your doctor gave you rather than coming earlier.
The reticulocyte count test is AED 25, including a physician-reviewed report, with results usually within 24 hours. Home collection anywhere in Dubai is free when your order reaches AED 300 or includes a package; below that, a AED 100 home collection fee applies (AED 50 for a lab walk-in).